Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model
Benjamin Lemasson(Université Joseph Fourier), Brian D. Ross(University of Michigan)
Cited by 27
Related Papers
Prospective Early Response Imaging Biomarker for Neoadjuvant Breast Cancer Chemotherapy
|Clinical Cancer Research|2007|88
A lymphatic-absorbed multi-targeted kinase inhibitor for myelofibrosis therapy
|Nature Communications|2022|14